Literature DB >> 212228

VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.

S R Bloom, J M Polak.   

Abstract

1. Plasma VIP immunoreactivity is always diagnostically raised in patients with pancreatic tumour causing the Verner-Morrison syndrome. 2. Human tumour VIP is physico-chemically similar to porcine VIP. 3. The only other situation in which plasma VIP is very elevated is in patients with ganglioneuroblastomas associated with diarrhoea. 4. VIP is not elevated in patients with diarrhoea associated with pancreatic islet hyperplasia, designated the pseudo Verner-Morrison syndrome.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 212228     DOI： 10.1111/j.1365-2265.1976.tb03831.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


  5 in total

1.  Fluid secretion in the duodenum and intestinal handling of water and electrolytes in Zollinger-Ellison syndrome.

Authors:  J C Rambaud; R Modigliani; P Emonts; C Matuchansky; N Vidon; H Besterman; J J Bernier
Journal:  Am J Dig Dis       Date:  1978-12

2.  Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.

Authors:  A Ruskoné; E René; J A Chayvialle; N Bonin; F Pignal; M Kremer; S Bonfils; J C Rambaud
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

3.  Chronic laxative abuse associated with pancreatic islet cell hyperplasia.

Authors:  M Lesna; A N Hamlyn; C W Venables; C O Record
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

Review 4.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

5.  Pancreatic apudomas.

Authors:  S R Bloom; J M Polak; R B Welbourn
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.